发明名称 INJIZIERBARES PHARMAZEUTISCHES THYROXINPRAEPARAT UND VERFAHREN ZU DESSEN HERSTELLUNG
摘要 <p>Prepns. consist of a soln. of a water-soluble salt of thyroxine substance and contain is not 50% water. Thyroxine substance is present in a concentration of >0.5 mg/ml., and the soln. additionally contains vitamin B12 in the same amt. as the thyroxine substance. The soln. is free from macromolecules and macro-ions. The gelling agents used in parent patent can be omitted from the formulation without adversely affecting stability, so that higher thyroxine does can be administered without the problems associated with high viscosity. In an example, parenteral formulation is prepd. by dissolving 120 g crystalline vitamin B12 and 120 mg sodium DL-thyroxine in 100 ml 0.9% NaCl solution.</p>
申请公布号 DE2546474(A1) 申请公布日期 1977.04.21
申请号 DE19752546474 申请日期 1975.10.17
申请人 ISRAEL,MURRAY M.D. 发明人 M.D. ISRAEL,MURRAY
分类号 A61K31/195;(IPC1-7):61K31/68;61K31/195 主分类号 A61K31/195
代理机构 代理人
主权项
地址